Mylan/Watson Emsam "Approvable"
This article was originally published in The Pink Sheet Daily
You may also be interested in...
Emsam Antidepressant Patch Approved; April Launch Anticipated
Bristol/Somerset’s product avoids MAOI-class dietary restrictions at the lowest dose.
Emsam Antidepressant Patch Approved; April Launch Anticipated
Bristol/Somerset’s product avoids MAOI-class dietary restrictions at the lowest dose.
Somerset's Low-Dose Emsam Patch Needs Dietary Restrictions, FDA Reviewer Says
Dietary restrictions for the 20 mg patch of the therapy for major depressive disorder will be reviewed by the Psychopharmacologic Drugs Advisory Committee on Oct. 26.